By: Jessica D. Bradley JONES DAY LLP This article discusses ex parte expungement and reexamination proceedings at the U.S. Patent and Trademark Office (USPTO). SUCH PROCEEDINGS SEEK FULL OR PARTIAL CANCELLATION of federal trademark registrations that...

By: Michael Furrow , DLA Piper, and Whitney Meier , Venable LLP The Biologics Price Competition and Innovation Act (BPCIA) provides an abbreviated pathway for companies to bring biologic drugs to market that are biosimilar to previously approved branded...

By: The Practical Guidance Tax Team This article discusses the Consolidated Appropriations Act (the Act), passed by the House and Senate on December 21, 2020, and signed by President Trump on December 27, 2020. The Act pairs a roughly $900 billion novel...

By: Eric E. Bensen. The Defend Trade Secrets Act (DTSA) 1 creates for the first time a federal private cause of action for trade secret misappropriation. 2 Prior to the DTSA’s enactment, private causes of action for trade secret misappropriation...

By: Jonathan B. Wilson TAYLOR ENGLISH DUMA LLP AND THE FinCEN REPORT COMPANY The Corporate Transparency Act As part of the William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021, 1 Congress adopted the Corporate Transparency...